Janssen and Johnson & Johnson Innovation Announces Collaboration With Belgian Scientists To Pursue New Research In Neurodegenerative Diseases
Circle Connections: Mergers & Acquisitions Janssen Research & Development, Division of Janssen Pharmaceutica NV, and Johnson & Johnson Innovation announced the launch of a collaborative initiative with scientists from three prominent Belgian academic institutions and research centers to drive discoveries to improve the prevention, diagnosis and treatment of neurodegenerative diseases. Janssen Research & Development and Johnson & Johnson Innovation are committing up to five million Euros for this project over a five-year period. The project seeks to attract top researchers in the Benelux scientific community to submit proposals for cutting-edge research in neurodegenerative disorders. Janssen Research & Development . . .
